With over 15 years of experience, Matt is a trusted advisor to organizations navigating high-stakes transformations. He specializes in guiding life sciences companies through the full deal continuum—from due diligence to integration or separation—helping them realize lasting value from strategic transactions. At Syner-G, Matt partners with clients to ensure their deals, whether in product lifecycle management, portfolio optimization, or M&A, deliver tangible results aligned with their business ambitions.

Having advised on more than 30 complex transactions globally, Matt brings deep hands-on expertise across pharmaceuticals, consumer products, and manufacturing sectors. His prior leadership roles at Pfizer and PwC provide him with clarity and direction in operational diligence, TSA governance, and integration planning across North America, Europe, and Asia. His practical, results-oriented approach emphasizes value realization, cross-functional alignment, and high-performing program architecture.

Matt excels at helping executive teams build strategic, data-driven programs that maximize deal value and facilitate seamless execution. His ability to simplify complexity and deliver measurable results has made him a trusted partner throughout the M&A lifecycle.

He holds an MBA in International Business and Business Analytics from The George Washington University and is Green Belt certified in Lean Six Sigma. Having lived and worked in Switzerland, China, and Brazil, Matt brings a truly global perspective to every engagement, empowering clients to confidently shape their futures through strategic transformation.